The Japanese government announced the supplementary budged related to the economic stimulus package concerning coronavirus disease (COVID-19) on April 20, 2020. A total expense of around 1.8 trillion Japanese yen was planned for medical and pharmaceutical related measures, 13.9 billion yen of which were for securing the antiviral drug Avigan (Favipiravir). Only 10 billion yen were for supporting the development of vaccines in the country, while close to 22 billion yen were prepared for supporting the development of vaccines internationally.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated facts and figures page.
Breakdown of governmental supplementary budget for medical and pharmaceutical related measures against coronavirus disease (COVID-19) in Japan announced on April 20, 2020
(in billion Japanese yen)
*To be allocated for measures implemented by local governments regarding Emergency Economic Package, depending on circumstances. **Includes grants for PCR screening devices, securing hospital beds and facilities for patients with slight symptoms, securing medical equipment, or assisting dispatch of supporting doctors, etc. ***Such as distributing masks to kindergartens, elementary schools, nursing homes, and other facilities.
100 Japanese yen equal 0.74 U.S. dollars or 0.70 euros as of December 2022.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Ministry of Finance Japan. (April 20, 2020). Breakdown of governmental supplementary budget for medical and pharmaceutical related measures against coronavirus disease (COVID-19) in Japan announced on April 20, 2020 (in billion Japanese yen) [Graph]. In Statista. Retrieved December 03, 2024, from https://www.statista.com/statistics/1118770/japan-government-supplementary-budget-coronavirus-medical-pharmaceutical-measures/
Ministry of Finance Japan. "Breakdown of governmental supplementary budget for medical and pharmaceutical related measures against coronavirus disease (COVID-19) in Japan announced on April 20, 2020 (in billion Japanese yen)." Chart. April 20, 2020. Statista. Accessed December 03, 2024. https://www.statista.com/statistics/1118770/japan-government-supplementary-budget-coronavirus-medical-pharmaceutical-measures/
Ministry of Finance Japan. (2020). Breakdown of governmental supplementary budget for medical and pharmaceutical related measures against coronavirus disease (COVID-19) in Japan announced on April 20, 2020 (in billion Japanese yen). Statista. Statista Inc.. Accessed: December 03, 2024. https://www.statista.com/statistics/1118770/japan-government-supplementary-budget-coronavirus-medical-pharmaceutical-measures/
Ministry of Finance Japan. "Breakdown of Governmental Supplementary Budget for Medical and Pharmaceutical Related Measures against Coronavirus Disease (Covid-19) in Japan Announced on April 20, 2020 (in Billion Japanese Yen)." Statista, Statista Inc., 20 Apr 2020, https://www.statista.com/statistics/1118770/japan-government-supplementary-budget-coronavirus-medical-pharmaceutical-measures/
Ministry of Finance Japan, Breakdown of governmental supplementary budget for medical and pharmaceutical related measures against coronavirus disease (COVID-19) in Japan announced on April 20, 2020 (in billion Japanese yen) Statista, https://www.statista.com/statistics/1118770/japan-government-supplementary-budget-coronavirus-medical-pharmaceutical-measures/ (last visited December 03, 2024)
Breakdown of governmental supplementary budget for medical and pharmaceutical related measures against coronavirus disease (COVID-19) in Japan announced on April 20, 2020 (in billion Japanese yen) [Graph], Ministry of Finance Japan, April 20, 2020. [Online]. Available: https://www.statista.com/statistics/1118770/japan-government-supplementary-budget-coronavirus-medical-pharmaceutical-measures/
